Fig. 1From: High-dose radiotherapy in newly diagnosed low-grade gliomas with nonmethylated O(6)-methylguanine-DNA methyltransferaseRT dose effects on MGMT status defined subtypes. Patients with MGMT-non-pM (A, B) could benefit from high-dose radiotherapy (> 54 Gy); Patients with MGMT-pM did not benefit from high-dose RT (C, D)Back to article page